Literature DB >> 17851420

Synthesis of gefitinib from methyl 3-hydroxy-4-methoxy-benzoate.

Ming Dong Li1, You Guang Zheng, Min Ji.   

Abstract

This paper reports a novel synthesis of gefitinib starting from methyl 3-hydroxy-4-methoxybenzoate. The process starts with alkylation of the starting material, followed by nitration, reduction, cyclization, chlorination and two successive amination reactions. The intermediates and target molecule were characterized by 1H-NMR, 13C-NMR, MS and the purities of all these compounds were determined by HPLC. This novel synthetic route produced overall yields as high as 37.4%.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851420      PMCID: PMC6149427          DOI: 10.3390/12030673

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  6 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  Targeting tyrosine kinases in cancer: the second wave.

Authors:  Jose Baselga
Journal:  Science       Date:  2006-05-26       Impact factor: 47.728

3.  Improved synthesis of substituted 6,7-dihydroxy-4-quinazolineamines: tandutinib, erlotinib and gefitinib.

Authors:  Petr Knesl; Dirk Röseling; Ulrich Jordis
Journal:  Molecules       Date:  2006-04-10       Impact factor: 4.411

Review 4.  Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development.

Authors:  Shantaram Kamath; John K Buolamwini
Journal:  Med Res Rev       Date:  2006-09       Impact factor: 12.944

5.  Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer.

Authors:  A J Barker; K H Gibson; W Grundy; A A Godfrey; J J Barlow; M P Healy; J R Woodburn; S E Ashton; B J Curry; L Scarlett; L Henthorn; L Richards
Journal:  Bioorg Med Chem Lett       Date:  2001-07-23       Impact factor: 2.823

6.  Synthesis of [11C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase.

Authors:  Ji-Quan Wang; Mingzhang Gao; Kathy D Miller; George W Sledge; Qi-Huang Zheng
Journal:  Bioorg Med Chem Lett       Date:  2006-05-11       Impact factor: 2.823

  6 in total
  1 in total

1.  Withdrawn paper: Li, M.D.; Zheng, Y.G.; Ji, M. Synthesis of gefitinib from methyl 3-hydroxy-4-methoxybenzoate. Molecules 2007,12,673-678.

Authors:  Derek J McPhee; Shu Kun Lin
Journal:  Molecules       Date:  2007       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.